Neda A. Moatamed, MD

Neda A. Moatamed, MD

Associate Professor, Department of Pathology and Laboratory Medicine


English, Persian (Farsi)



Institutional Affiliation

Ronald Reagan UCLA Medical Center



Pathology, UCLA School of Medicine, 2005 - 2006
Cytopathology, LAC + USC Medical Center, 2004 - 2005
Surgical Pathology, LAC + USC Medical Center, 2003 - 2004


Pathology, LAC + USC Medical Center, 1999 - 2000


MD, Iran University of Medical Sciences, 1996


Anatomic and Clinical Pathology, LAC + USC Medical Center, 2000 - 2003

Board Certifications

Cytopathology, American Board of Pathology, 2005
Anatomic Pathology and Clinical Pathology, American Board of Pathology, 2004

Contact Information

Scientific Interests

Dr. Neda Moatamed is interested in understanding the clinical and pathological behavior of gynecologic neoplasms and breast cancers. She is also interested in studying the molecular and genetic pathways in breast and gynecological tumors.

Highlighted Publications

Reddy OL, Shintaku PI, Moatamed NA. Programmed death-ligand 1 (PD-L1) is expressed in a significant number of the uterine cervical carcinomas. Diagn Pathol. 2017 Jun 17;12(1):45. doi: 10.1186/s13000-017-0631-6.

Soh H, Venkatesan N, Veena MS, Ravichandran S, Zinabadi A, Basak SK, Parvatiyar K, Srivastava M, Liang LJ, Gjertson DW, Torres JZ, Moatamed NA, Srivatsan ES. Cystatin E/M Suppresses Tumor Cell Growth through Cytoplasmic Retention of NF-KappaB. Mol Cell Biol. 2016 May 31;36(12):1776-92. doi: 10.1128/MCB.00878-15. Print 2016 Jun 15.

Woo JS, Apple SK, Sullivan PS, Rao JY, Ostrzega N, Moatamed NA. Systematic assessment of HER2/neu in gynecologic neoplasms, an institutional experience. Diagn Pathol. 2016 Oct 22;11(1):102.

Engelberg JA, Retallack H, Balassanian R, Dowsett M, Zabaglo L, Ram AA, Apple SK, Bishop JW, Borowsky AD, Carpenter PM, Chen YY, Datnow B, Elson S, Hasteh F, Lin F, Moatamed NA, Zhang Y, Cardiff RD. "Score the Core" Web-based pathologist training tool improves the accuracy of breast cancer IHC4 scoring. Hum Pathol. 2015 Nov;46(11):1694-704. doi: 10.1016/j.humpath.2015.07.008. Epub 2015 Jul 29.

Yang SE, Sullivan PS, Zhang J, Govind R, Levin MR, Rao JY, Moatamed NA. Has Afirma gene expression classifier testing refined the indeterminate thyroid category in cytology? Cancer Cytopathol. 2016 Feb;124(2):100-9. doi: 10.1002/cncy.21624. Epub 2015 Sep 30.